Diagnostic Imaging's Top Five Prostate Imaging Content of 2024

News
Slideshow

Catch up on the most well-viewed prostate imaging content from 2024.

As we come to the end of 2024, we take a look back at the most well-read prostate imaging content with topics ranging from predictive factors for metastatic prostate cancer to the use of prostate MRI for active surveillance and PSMA PET/CT-guided radiotherapy for oligometastatic prostate cancer. Review the slideshow below to see highlighted prostate imaging content from the past year.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Related Content
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound

BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound

Jeff Hall
May 14th 2025
Article

The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

GE HealthCare Introduces Signa Sprint 1.5T MRI System at ISMRM Conference

GE HealthCare Introduces Signa Sprint 1.5T MRI System at ISMRM Conference

Jeff Hall
May 12th 2025
Article

The combination of high-performance gradient technology and AI tools with the Signa Sprint MRI reportedly facilitate enhanced MRI workflow efficiencies in cardiac and oncology imaging.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

What a New MRI Meta-Analysis Reveals About AI-Powered Hippocampal Segmentation and Alzheimer’s Disease

What a New MRI Meta-Analysis Reveals About AI-Powered Hippocampal Segmentation and Alzheimer’s Disease

Jeff Hall
May 8th 2025
Article

While AI-enabled hippocampal segmentation on MRI offered a 95 percent AUC for differentiating between Alzheimer’s disease and normal controls in a 27-study meta-analysis, it offered significantly lower sensitivity and specificity in differentiating mild cognitive impairment.

Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging

Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging

Jeff Hall
May 7th 2025
Article

For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.

© 2025 MJH Life Sciences

All rights reserved.